Intangible outcomes from a policy change: using contingent valuation to quantify potential stigma from a cannabis offence

ObjectiveNew policies are increasingly required to be evaluated. One form of evaluation is a cost–benefit analysis where inputs and outcomes are all valued monetarily. However, intangible outcomes are often not included in these evaluations as they are perceived to be too difficult to value. The aim of this paper is to value one of the intangible benefits (decrease in stigma) from a potential change in drug policy using contingent valuation.MethodsThis paper reports on a contingent valuation study conducted among a community sample of 875 respondents on the internet. Respondents were asked what they would be willing to pay to avoid the stigma of a criminal record. Data were analysed with descriptive and regression analyses.ResultsThe survey found respondents were willing to pay a mean of $1,231 ($1,112–1,322; AUD 2009) to avoid the stigma from a criminal record for a loved one or for themselves. Household income was an important predictor of willingness-to-pay (WTP). The WTP was significantly and positively related to whether the respondent believed cannabis was usually or always addictive while those who had used cannabis recently (within past 12 months) were less likely to pay more, relative to those who had not used recently.ConclusionsThis paper demonstrates the feasibility of using economic methods to value intangible benefits from drug policy changes.

[1]  S. Lenton,et al.  Arrest, Court and Social Impacts of Conviction for a Minor Cannabis Offense under Strict Prohibition , 2000 .

[2]  F. Carrat,et al.  "If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question". Evidence from a double-bounded dichotomous choice model with heterogeneous anchoring. , 2009, Journal of health economics.

[3]  Richard D. Smith,et al.  It's not just what you do, it's the way that you do it: the effect of different payment card formats and survey administration on willingness to pay for health gain. , 2006, Health economics.

[4]  Jeffrey M. Wooldridge,et al.  Introductory Econometrics: A Modern Approach , 1999 .

[5]  P. Reuter,et al.  Cannabis Policy: Moving Beyond Stalemate , 2010 .

[6]  P. Gruenewald,et al.  Preventing Harmful Substance Use , 2005 .

[7]  S. Mourato,et al.  Cost-Benefit Analysis and the Environment: Recent Developments , 2006 .

[8]  Richard D. Smith Construction of the contingent valuation market in health care: a critical assessment. , 2003, Health economics.

[9]  S. Galea,et al.  Stigma, discrimination and the health of illicit drug users. , 2007, Drug and alcohol dependence.

[10]  A. Boardman,et al.  Cost-Benefit Analysis: Concepts and Practice , 1996 .

[11]  Richard D. Smith,et al.  The Discrete-choice Willingness-to-pay Question Format in Health Economics: , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  P. Cook,et al.  The Benefits of Reducing Gun Violence: Evidence from Contingent-Valuation Survey Data , 1999 .

[13]  J. Olsen,et al.  Theory versus practice: a review of 'willingness-to-pay' in health and health care. , 2001, Health economics.

[14]  J. J. R. Lott An Attempt at Measuring the Total Monetary Penalty from Drug Convictions: The Importance of an Individual's Reputation , 1992, The Journal of Legal Studies.

[15]  S. Lenton Deterrence Theory and the Limitations of Criminal Penalties for Cannabis Use , 2009 .

[16]  N. Hanley,et al.  Cost–Benefit Analysis and the Environment , 1994 .

[17]  C. Hughes,et al.  A SUMMARY OF DIVERSION PROGRAMS FOR DRUG AND DRUG-RELATED OFFENDERS IN AUSTRALIA , 2008 .

[18]  J. Dijk The Narrow Margins of the Dutch Drug Policy: A Cost-Benefit Analysis , 1998 .

[19]  K. Furuya A socio-economic model of stigma and related social problems , 2002 .

[20]  S. Fiske,et al.  The Handbook of Social Psychology , 1935 .

[21]  Nahid Golafshani,et al.  Understanding Reliability and Validity in Qualitative Research , 2003 .

[22]  Alex R. Piquero,et al.  How Much is the Public Willing to Pay to be Protected from Identity Theft? , 2011 .

[23]  D. McDonald,et al.  The prohibition of illicit drugs is killing and criminalising our children and we are all letting it happen. , 2012 .

[24]  M. Haden Controlling illegal stimulants: a regulated market model , 2008, Harm reduction journal.

[25]  Simon T. Tidd,et al.  Willingness-to-Pay for Crime Control Programs , 2001 .

[26]  A. Wodak,et al.  Cannabis control: costs outweigh the benefits , 2002, BMJ : British Medical Journal.

[27]  J. Borghi Aggregation rules for cost-benefit analysis: a health economics perspective. , 2008, Health economics.

[28]  Denzil G. Fiebig,et al.  Consumers and experts: an econometric analysis of the demand for water heaters , 2006 .

[29]  Jordan J. Louviere,et al.  Applied Methods of Cost-Benefit Analysis in Health Care , 2010 .

[30]  A. Vining,et al.  An Assessment of Important Issues Concerning the Application of Benefit-Cost Analysis to Social Policy , 2010, Journal of Benefit-Cost Analysis.

[31]  Giles Atkinson,et al.  Valuing the costs of violent crime: a stated preference approach , 2005 .

[32]  Aki Tsuchiya,et al.  Estimating the Intangible Victim Costs of Violent Crime , 2005 .

[33]  Patricia A. Champ,et al.  Survey Methodologies for Stated-Choice Studies , 2006 .

[34]  M. Krohn,et al.  Labeling and Cumulative Disadvantage , 2012 .

[35]  N. Powe,et al.  Estimating the Value of Improved Street Lighting: A Factor Analytical Discrete Choice Approach , 2005 .

[36]  A. Jacoby,et al.  Felt versus enacted stigma: a concept revisited. Evidence from a study of people with epilepsy in remission. , 1994, Social science & medicine.

[37]  J. Baker,et al.  The Cannabis Cautioning Scheme Three Years On: An Implementation and Outcome Evaluation , 2004 .

[38]  Søren Bøye Olsen,et al.  Choosing Between Internet and Mail Survey Modes for Choice Experiment Surveys Considering Non-Market Goods , 2009 .

[39]  M. Jones-Lee,et al.  Valuation of Health Benefits Associated with Reductions in Air Pollution , 2004 .

[40]  D. Pager The Mark of a Criminal Record1 , 2003, American Journal of Sociology.

[41]  Craig G. A. Jones,et al.  Prohibition and Cannabis Use in Australia: A Survey of 18- to 29-year-olds , 2003 .

[42]  Patricia Funk On the effective use of stigma as a crime-deterrent , 2004 .

[43]  A Gafni,et al.  Health care contingent valuation studies: a review and classification of the literature. , 1998, Health economics.

[44]  A. Hathaway,et al.  Cannabis normalization and stigma: Contemporary practices of moral regulation , 2011 .

[45]  U. Fischer War on drugs , 2013 .

[46]  Paul Dolan,et al.  ESTIMATING THE ECONOMIC AND SOCIAL COSTS OF THE FEAR OF CRIME , 2007 .

[47]  M. Johannesson,et al.  Outcome measurement in economic evaluation. , 1996, Health economics.

[48]  K. Upton,et al.  A modern approach , 1995 .

[49]  Emily Lancsar,et al.  Choice experiments in health: the good, the bad, the ugly and toward a brighter future , 2009, Health Economics, Policy and Law.

[50]  C. Hughes,et al.  The effects of the decriminalization of drug use in Portugal , 2007 .

[51]  D. Mcknight Beyond Right and Left: New politics and the culture wars , 2005 .

[52]  Richard D. Smith Use, option and externality values: are contingent valuation studies in health care mis-specified? , 2007, Health economics.

[53]  E. Rasmusen Stigma and Self-Fulfilling Expectations of Criminality , 1996, The Journal of Law and Economics.

[54]  Peter Abelson Public Economics: Principles and Practice , 2008 .

[55]  C. Lloyd Sinning and Sinned Against: The Stigmatisation of Problem Drug Users , 2010 .